Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M803622200 on October 24, 2008

J. Biol. Chem., Vol. 283, Issue 51, 35908-35917, December 19, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/51/35908    most recent
M803622200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nafisi, H.
Right arrow Articles by Albert, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nafisi, H.
Right arrow Articles by Albert, P. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

GAP1(IP4BP)/RASA3 Mediates G{alpha}i-induced Inhibition of Mitogen-activated Protein Kinase*Formula

Houman Nafisi1, Behzad Banihashemi, Mireille Daigle, and Paul R. Albert2

From the Ottawa Health Research Institute (Neuroscience), Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa K1H 8M5, Canada

The dopamine D2S receptor (short isoform) couples to inhibitory G{alpha}i/o proteins to inhibit thyrotropin-releasing hormone (TRH)-stimulated p42/p44 mitogen-activated protein kinase (ERK1/2) phosphorylation in GH4ZR7 rat pituitary cells, consistent with its actions to inhibit prolactin gene transcription and cell proliferation. However, the underlying mechanism is unclear. To identify novel G{alpha}i effectors, yeast two-hybrid screening of a GH4ZR7 cDNA library was done using constitutively active G{alpha}i3-Q204L, and multiple clones of the RasGAP cDNA GAP1IP4BP/RASA3 were identified. In yeast mating assay, RASA3 preferentially interacted with activated forms of G{alpha}i/o/z proteins, but not with G{alpha}s. A direct interaction was indicated by in vitro pull-down assay, in which S-His-RASA3 preferentially bound guanosine 5'-O-({gamma}-thio)triphosphate-activated G{alpha}i3 and G{alpha}i2 compared with guanosine 5'-O-(β-thio)diphosphate-inactivated proteins. Similarly, in co-immunoprecipitation studies in HEK-293 cells, FLAG-tagged RASA3 preferentially interacted with activated mutants of G{alpha}i3 and G{alpha}i2 compared with wild type proteins. In GH4ZR7 cells, co-immunoprecipitation studies of endogenous proteins demonstrated a G{alpha}i3-RASA3 complex that was induced upon TRH/D2S receptor co-activation. To address RASA3 function in dopamine D2S receptor-induced inhibition of ERK1/2 activity, endogenous RASA3 protein expression was suppressed (70% knockdown) in GH4ZR7 cells stably transfected with full-length antisense cDNA of RASA3. The selected antisense clones had similar levels of dopamine D2S receptor binding and D2S-induced inhibition of cAMP formation compared with parental GH4ZR7 cells. In these clones, D2S-mediated inhibition of TRH-induced phospho-ERK1/2 was reversed by 70-80% compared with parental GH4ZR7 cells. Our results provide a novel mechanism for dopamine D2S-induced inhibition of ERK1/2 and indicate that RASA3 links G{alpha}i proteins to inhibit Gq-induced Ras/ERK1/2 activation.


Received for publication, May 12, 2008 , and in revised form, September 17, 2008.

* This work was supported by grants from the Canadian Institutes of Health and the Ontario Mental Health Research (to P. R. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1.

1 Supported by Ontario Graduate Scholarship.

2 Canadian Institutes of Health Research/Novartis Michael Smith Chair in Neurosciences. To whom correspondence should be addressed. Tel.: 613-562-5800, Ext. 8307; Fax: 613-562-5403; E-mail: palbert{at}uottawa.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement